June 22, 2021
Teva Pharmaceuticals USA Inc. has agreed to shell out $925,000 to the state of Mississippi to resolve claims in Pennsylvania federal court that the drug giant and subsidiary Actavis Holdco US Inc. conspired with others to fix the prices of generic medicines, a company spokesperson told Law360 Tuesday.
May 14, 2021
State attorneys general on Friday blasted a bid by generic-drug makers to use a recent U.S. Supreme Court ruling as a shield against the prosecutors' price-fixing claims, telling a Pennsylvania federal court that the justices' decision doesn't address the relevant law.
May 06, 2021
The potential influence of the U.S. Supreme Court decision striking down the Federal Trade Commission's claimed authority to recover ill-gotten gains in federal court continues to spread, with generic-drug makers citing the ruling Wednesday to fight state attorneys general's price-fixing claims in sprawling Pennsylvania federal court litigation.
November 03, 2020
Generic drug companies and their executives launched a multipronged attack Monday on one of three complaints filed by state attorneys general amid sprawling multidistrict litigation alleging an industrywide price-fixing conspiracy, arguing it was likely meant as an end-run around limits on amending the other complaints.
June 10, 2020
State enforcers added more treatments to their price-fixing case against generic-drug makers with a third complaint Wednesday in Connecticut federal court accusing 26 companies and 10 individuals of "rampant" collusion on topically applied treatments.
March 02, 2020
A generic-drug maker should face price-fixing allegations by 44 states, two state attorneys general told a Pennsylvania federal judge, saying there's ample evidence the company joined in a conspiracy with Teva.
February 21, 2020
A case brought by 44 state attorneys general against Teva Pharmaceuticals and several other drugmakers should be the bellwether for a massive multidistrict litigation over alleged conspiracies to fix the prices of generic drugs, according to a special master's report Thursday.
February 18, 2020
A former Teva executive has urged a Pennsylvania federal judge to toss price-fixing accusations against her from a coalition of 44 state attorneys general as part of multidistrict litigation alleging industrywide price-fixing by generic-drug makers, blasting the claims as "threadbare."
January 29, 2020
A coalition of state attorneys general is bashing Pfizer's attempt to exit multidistrict litigation alleging industrywide price-fixing by generic-drug makers, asserting that Pfizer must be held accountable for its generic-drug subsidiary's alleged involvement in the scheme because the companies are "one and the same."
December 02, 2019
Pfizer Inc. is seeking to exit the sweeping Pennsylvania multidistrict litigation alleging it conspired with other major drugmakers to keep generic prices high, as the branded drugmaker said its only ties to the allegations stem from a subsidiary, and that's not enough.